L50.0

Allergic urticaria

Allergic urticaria is a Type I hypersensitivity reaction (IgE-mediated) characterized by the sudden onset of wheals and hives on the skin. The condition is triggered when an allergen, to which the individual has been previously sensitized, cross-links specific IgE antibodies on the surface of mast cells and basophils. This interaction leads to cellular degranulation and the release of potent inflammatory mediators, primarily histamine, as well as leukotrienes and prostaglandins. These substances cause localized vasodilation and increased capillary permeability within the superficial dermis, resulting in the characteristic edematous, pruritic lesions. Individual wheals are typically evanescent, resolving within 24 hours without leaving permanent marks, although new lesions may erupt periodically as long as the allergen or inflammatory cascade persists. Allergic urticaria may occur in isolation or as a cutaneous manifestation of systemic anaphylaxis, necessitating careful clinical monitoring.

Clinical Symptoms

  • Pruritic wheals (hives) of varying shapes and sizes
  • Erythematous borders with central pallor
  • Blanching (whitening) of lesions when pressure is applied
  • Angioedema (swelling of deep dermal, subcutaneous, or mucosal tissues), commonly affecting the lips or eyes
  • Evanescent lesions that typically resolve within 24 hours
  • Intense itching (pruritus)
  • Burning or stinging sensation at the site of the wheals
  • Circumscribed, raised plaques that may coalesce into larger patches
  • Dermatographic response (skin whealing in response to scratching)

Common Causes

  • Food allergens such as peanuts, tree nuts, shellfish, eggs, and milk
  • Pharmacological triggers including antibiotics (e.g., penicillins, sulfonamides) and NSAIDs
  • Hymenoptera venom from bee, wasp, or hornet stings
  • Environmental allergens such as pollen, animal dander, and mold spores
  • Latex proteins
  • Blood products and transfusion-related reactions
  • Inhaled allergens (less common)
  • Contact allergens (e.g., certain chemicals, plants, or animal saliva)

Documentation & Coding Tips

Document the specific triggering agent or allergen causing the allergic urticaria to ensure maximum specificity and to support medical necessity for testing.

Example: Patient presents with acute onset of erythematous, pruritic wheals on the bilateral upper extremities and torso following ingestion of walnuts. Clinical assessment confirms allergic urticaria due to tree nut exposure. Plan includes intramuscular diphenhydramine and prescription for epinephrine auto-injector. Condition is acute and severe, impacting daily activities and posing risk for progression to anaphylaxis.

Billing Focus: Identify the external cause or allergen to link the diagnosis to appropriate V, W, X, or Y codes if applicable, supporting the complexity of the encounter.

Specify the duration of the episode and whether the condition is acute or chronic to differentiate between L50.0 and other urticaria subcategories.

Example: Diagnosis of allergic urticaria, acute, manifesting as migratory wheals for 48 hours following exposure to latex. No evidence of chronic idiopathic urticaria. Patient is stable but requires moderate medical decision making to rule out late-phase reactions. History of asthma increases risk for severe respiratory compromise.

Billing Focus: Differentiating acute versus chronic status impacts the choice of E/M level and supports the necessity of follow-up care.

Describe the morphology and distribution of the lesions to support the clinical diagnosis and distinguish from other dermatological conditions.

Example: Physical exam reveals multiple raised, blanchable, circumscribed wheals with central pallor and surrounding erythema distributed across the abdomen and thighs. Lesions are highly pruritic and evanescent, typical of allergic urticaria. No evidence of vasculitic changes or blistering. Patient currently on ACE inhibitors which may exacerbate the bradykinin-mediated response.

Billing Focus: Detailed physical exam findings support the medical necessity for the level of E/M service and provide evidence for procedure-based treatments.

Record the presence or absence of angioedema, as this significantly changes the clinical management and the risk level of the patient.

Example: Allergic urticaria secondary to penicillin administration. Patient exhibits significant swelling of the lips and periorbital tissue consistent with angioedema. No laryngeal edema or stridor noted. Risk of airway obstruction is high, necessitating observation and high-intensity management with systemic corticosteroids and antihistamines.

Billing Focus: Documentation of angioedema may require an additional code (T78.3-) which increases the complexity and reimbursement for the encounter.

Indicate the failure or success of previous treatments such as OTC H1 blockers to justify the escalation to H2 blockers, leukotriene modifiers, or systemic steroids.

Example: Patient with persistent allergic urticaria refractory to maximum doses of cetirizine and loratadine. Initiating prednisone 40mg daily for 5 days with a gradual taper and adding famotidine 20mg BID. Complexity is moderate due to the need to monitor for steroid-induced side effects in this diabetic patient.

Billing Focus: Documenting treatment failure supports the medical necessity for higher-level drugs or specialty referrals (CPT 99214).

Relevant CPT Codes

Related Diagnoses

Hierarchy